CompletedNot Applicable

Microcirculation of the Abdominal Skin After Deep Inferior Epigastric Artery Perforator Flap Procedure

Norway20 participantsStarted 2008-01

Plain-language summary

The purpose of this study was to perform a quantitative perfusion study of the undermined abdominal skin in deep inferior epigastric artery perforator flap breast reconstruction patients in order to obtain more knowledge on perfusion dynamics. Laser Doppler perfusion imaging (LDPI) was used to evaluate this. Microcirculatory changes were monitored in the abdominal skin of 20 consecutive patients. Measurements were taken and recorded within four standardized zones covering the skin between the xiphoid process and the upper incisional boundary of the flap (zone 1-4; cranial to caudal).

Who can participate

Sex

FEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Secondary, unilateral breast reconstruction with a DIEAP * All smokers stopped smoking 4 weeks prior to surgery Exclusion Criteria: * Metastatic disease * Bilateral breast reconstruction

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Perfusion of the abdominal zones measured in mean perfusion units

Timeframe: Preoperative

Perfusion of the abdominal zones measured in mean perfusion units

Timeframe: two hours (After raising the flap)

Perfusion of the abdominal zones measured in mean perfusion units

Timeframe: Three hours (After undermining)

Perfusion of the abdominal zones measured in mean perfusion units

Timeframe: Five hours (After abdominal closure)

Perfusion of the abdominal zones measured in mean perfusion units

Timeframe: Postoperative day 1 (POD1)

Perfusion of the abdominal zones measured in mean perfusion units

Timeframe: Postoperative day 3 (POD3)

Perfusion of the abdominal zones measured in mean perfusion units

Timeframe: Postoperative day 7 (POD7)

Trial details

NCT IDNCT02481284

SponsorOslo University Hospital

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2009-09

View on ClinicalTrials.gov More Breast Reconstruction trials

Plain-language summary

Who can participate

Sex

FEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

What they're measuring

Perfusion of the abdominal zones measured in mean perfusion units

Timeframe: Preoperative

Perfusion of the abdominal zones measured in mean perfusion units

Timeframe: two hours (After raising the flap)

Perfusion of the abdominal zones measured in mean perfusion units

Timeframe: Three hours (After undermining)

Perfusion of the abdominal zones measured in mean perfusion units

Timeframe: Five hours (After abdominal closure)

Perfusion of the abdominal zones measured in mean perfusion units

Timeframe: Postoperative day 1 (POD1)

Perfusion of the abdominal zones measured in mean perfusion units

Timeframe: Postoperative day 3 (POD3)

Perfusion of the abdominal zones measured in mean perfusion units

Timeframe: Postoperative day 7 (POD7)